Seyed Moayed Alavian
Overview
Explore the profile of Seyed Moayed Alavian including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
367
Citations
3423
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Heiat M, Javanbakht M, Jafari D, Poudineh M, Heydari F, Sharafi H, et al.
Cytokine
. 2024 Dec;
186():156818.
PMID: 39671883
Background: Patients who have been infected with the Hepatitis B virus (HBV) are susceptible to developing liver cirrhosis (LC) and hepatocellular carcinoma (HCC). The objective of this systematic review was...
2.
Nejad S, Heiat M, Javanbakht M, Alavian S, Haris M
BMC Gastroenterol
. 2024 Jan;
24(1):17.
PMID: 38178070
Background: Autoimmune liver diseases (AILD) are increasing and common forms of chronic liver disease (CLD) with different clinical responses and characteristics which can result in cirrhosis. This study aimed to...
3.
Dashti F, Alavian S, Sohrabpour A, Mousavi S, Keshavarz S, Esmaillzadeh A
BMJ Open
. 2023 Apr;
13(4):e063988.
PMID: 37117000
Introduction: Non-alcoholic fatty liver disease (NAFLD) is a hepatic condition that is considerably prevalent across the world. Dietary intakes, in which macronutrient composition is precisely planned, might be able to...
4.
Allahmoradi E, Mohammadi R, Zarandi P, Alavian S, Heiat M
Expert Rev Clin Immunol
. 2023 Apr;
19(6):671-688.
PMID: 37013795
Introduction: The hepatitis B virus (HBV) continues to be a leading cause of morbidity and mortality worldwide. In developing countries, HBV is the most common etiology of those liver diseases...
5.
Hashemi Yeganeh H, Heiat M, Alavian S, Rezaei E
Protein J
. 2022 Aug;
41(4-5):527-542.
PMID: 36001255
Along with all cancer treatments, including chemotherapy, radiotherapy, and surgery, targeting therapy is a new treatment manner. Immunotoxins are new recombinant structures that kill cancer cells by targeting specific antigens....
6.
Salehi-Sahlabadi A, Kord-Varkaneh H, Kocaadam-Bozkurt B, Seraj S, Alavian S, Hekmatdoost A
Phytother Res
. 2022 Jul;
36(11):4201-4209.
PMID: 35843540
Globally, Non-alcoholic fatty liver disease (NAFLD) has a rising prevalence with no definitive pharmacological treatments. The aim of this study was to assess the clinical effects of wheat germ in...
7.
Mohammadi H, Alavian S, Sharafi H
Int Immunopharmacol
. 2022 Jun;
110:108982.
PMID: 35752129
Background: Studies have reported that the immune system modulation genes are involved in the seroconversion during hepatitis B virus (HBV) infection. Here, a systematic review with meta-analysis is implemented on...
8.
Pourkarim M, Nayebzadeh S, Alavian S, Hataminasab S
Pathogens
. 2022 Jun;
11(6).
PMID: 35745480
New technologies are supported by the global implementation of the internet. These improvements have deeply affected various disciplines of sciences and consequently changed services such as daily business, particularly health...
9.
Tasavon Gholamhoseini M, Sharafi H, Hl Borba H, Alavian S, Sabermahani A, Hajarizadeh B
BMJ Open
. 2022 Jun;
12(6):e058757.
PMID: 35676019
Introduction: Low-cost generic direct-acting antiviral (DAA) regimens for treatment of hepatitis C virus (HCV) are available in several low-income/middle-income countries, important for treatment scale-up. This study evaluated the cost-effectiveness of...
10.
Ebrahimi-Mousavi S, Alavian S, Sohrabpour A, Dashti F, Djafarian K, Esmaillzadeh A
BMC Gastroenterol
. 2022 Mar;
22(1):102.
PMID: 35255811
Background: Given the increasing prevalence of non-alcoholic fatty liver disease, it is necessary to find an easy and cost-effective method in its management and treatment. Probiotics are a group of...